This is a working overview of clinical development, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-01-08. Anything still debated is marked as such rather than presented as settled.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
| Property | Value | Notes |
|---|---|---|
| Molecular weight | Approximately 4,700 Da | Peptide of roughly forty amino acids |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist class |
| Research code | LY3437943 | Internal development designation |
| Compound class | Incretin mimetic peptide | Synthetic, not a biologic extract |
| Development status | Investigational | No general regulatory approval |
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
==== Neuroregeneration ==== Regenerative strategies within the central nervous system (CNS) and peripheral nervous system (PNS) address severe impairments caused by spinal cord injuries, ischemic strokes, and neurodegenerative disorders such as Parkinson's disease. The therapeutic microenvironment of the adult brain and spinal cord is highly inhibitory to axon growth due to the formation of glial scars and chondroitin sulfate proteoglycans. Neuroregeneration research utilizes injectable hydrogels, shear-thinning biomaterials, and electrospun guidance conduits to physically bridge lesion cavities. These scaffolds are frequently loaded with neural stem cells (NSCs), neurotrophic growth factors, or enzyme-releasing agents to neutralize inhibitory molecular cues, support survival of transplanted dopaminergic or motor neurons, and provide a permissive physical framework for directed axonal elongation and synaptogenesis.
All I can personally do, at least for now, is stuff like this." Laidlaw also contributed to Valve's puzzle series Portal, which is set in the Half-Life universe. He disliked the crossover, feeling it "made both universes smaller", and said later: "I just had to react as gracefully as I could to the fact that it was going there without me. It didn't make any sense except from a resource-restricted point of view."
There is high interindividual variability in the levels of estradiol achieved with oral estradiol, which is likely related to the high first-pass effect. This variation has been reported to be in the range of 28 to 127%, or about 4.6-fold maximal difference in levels between individuals, in terms of mean area-under-the-curve levels of estradiol. In postmenopausal women, a dosage of 1 mg/day oral micronized estradiol has been found to produce circulating concentrations of 30 to 50 pg/mL estradiol and 150 to 300 pg/mL estrone, while a dosage of 2 mg/day has been found to result in circulating levels of 50 to 180 pg/mL estradiol and 300 to 850 pg/mL estrone. A study of oral micronized estradiol in transgender women found that mean estradiol levels across a dosage range of 1 to 8 mg/day were about 50 pg/mL at 1 mg/day, 100 pg/mL at 4 mg/day, and 150 pg/mL at 8 mg/day, with a wide degree of variation. In another study, mean estradiol levels at steady state with 4 mg/day and 6 mg/day oral micronized estradiol were approximately 180 pg/mL and 265 pg/mL, respectively. A study that used high to very high-dose oral micronized estradiol in postmenopausal women found that steady-state estradiol levels with 6 mg/day were about 300 pg/mL and with 30 mg/day were about 2,400 pg/mL. Estradiol valerate is rapidly hydrolyzed into estradiol in the intestines. For this reason, oral estradiol and oral estradiol valerate have very similar pharmacokinetics.
In the early months of 2010, the economic crisis worsened due to the outbreak of the European debt crisis initiated by the Greek government-debt crisis. Immediately, the debt of the rest of the Eurozone countries which, as in the case of Spain, presented a strong deficit in their balance of payments began to be "attacked" in the financial markets with the consequent increase of the risk premium with respect to the German bond. Then the creditor countries of the Eurozone, led by Germany, imposed on the debtors to decrease their public spending to reduce the budget deficit. The European institutions' ultimatum to the Spanish government came at the European Council meeting of May 9, 2010. Three days later, on May 12, Prime Minister Rodríguez Zapatero announced in Congress a drastic cut in public spending to the tune of 15 billion euros – civil servants' salaries were reduced by 5%, pensions were frozen, investment in infrastructure was paralyzed, among other measures – thus consummating the turn of the Socialist government's economic policy towards "adjustment" policies. The consequence was to nip the incipient recovery in the bud and cause the fall into a new recession at the end of 2011, with the consequent increase in unemployment.
Other scarab beetles, for example, Coprophanaeus ensifer, build their burrows near carcasses for easier transportation of carrion pieces to offspring. Beetles that feed on human remains are important in forensic science. Terrestrial beetles such as checkered beetles and dermestid beetles colonize bodies in a predictable sequence and have well-characterized life cycles, so they can sometimes be used to estimate time of death. Aquatic beetles are less useful for estimating time of death but can cause physical damage to submerged bodies that must be distinguished from inflicted injuries when determining cause of death. For example, the facultatively necrophagous diving beetle Meridiorhantus validus creates postmortem channels and chambers in human bodies that must be differentiated from antemortem piercing injuries.
Sources: en.wikipedia.org
== Types == While the initial vaccine in the 1940s was based on inactivated virus, subsequent preparations since the 1960s consist of live virus that has been weakened. It is on the World Health Organization's List of Essential Medicines. There are a number of different types in use as of 2007. Mumpsvax is Merck's brand of Jeryl Lynn strain vaccines. It is a component of Merck's three-virus MMR vaccine, and is the mumps vaccine standard in the United States. Mumpsvax is given by a subcutaneous injection of live virus reconstituted from freeze-dried (lyophilized) vaccine. Production of Mumpsvax as a stand-alone product ceased in 2009. The cells used in culture, virus stocks used, and animal fluids are all screened for extraneous material as part of the vaccine production. They are grown in Medium 199 (a solution containing buffered salt, vitamins, amino acids, fetal bovine serum) with SPGA (sucrose, phosphate, glutamate, human serum albumin) and neomycin. The human albumin processing uses the Cohn cold ethanol fractionation method.
Additionally, in many places, embalming is not done by specialist embalmers, but rather by doctors, medical technicians or laboratory technicians who, while they have the required anatomical or chemical knowledge, are not trained specialists in this field. Today, embalming is a common practice in North America, Australia, New Zealand, Britain and Ireland, while it is much less frequent in many parts of Europe; most modern countries have embalming available in some manner.
=== Activation by protease and metalloprotease === Plasmin and a member of matrix metalloproteinases (MMP) play a key role in promoting tumor invasion and tissue remodeling by inducing proteolysis of several ECM components. The TGF-β activation process involves the release of the LLC from the matrix, followed by further proteolysis of the LAP to release TGF-β to its receptors. MMP-9 and MMP-2 are known to cleave latent TGF-β. The LAP complex contains a protease-sensitive hinge region which can be the potential target for this liberation of TGF-β. Despite the fact that MMPs have been proven to play a key role in activating TGF-β, mice with mutations in MMP-9 and MMP-2 genes can still activate TGF-β and do not show any TGF-β deficiency phenotypes, this may reflect redundancy among the activating enzymes suggesting that other unknown proteases might be involved.
Most rheumatic diseases are treated with analgesics, NSAIDs (nonsteroidal anti-inflammatory drug), steroids (in serious cases), DMARDs (disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept, and methotrexate for moderate to severe rheumatoid arthritis. The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis. Physiotherapy is vital in the treatment of many rheumatological disorders. Occupational therapy can help patients find alternative ways for common movements that would otherwise be restricted by their disease. Patients with rheumatoid arthritis often need a long term, coordinated and a multidisciplinary team approach towards management of individual patients. Treatment is often tailored according to the individual needs of each patient which is also dependent on the response and the tolerability of medications. Beginning in the 2000s, the incorporation of biopharmaceuticals (which include inhibitors of TNF-alpha, certain interleukins, and the JAK-STAT signaling pathway) into standards of care is one of the paramount developments in modern rheumatology.
Sources: en.wikipedia.org
==== Climbing Chimborazo ==== Humboldt and Bonpland began their ascent of Chimborazo from the plain of Tapia, situated at 3,163 yards (2,892 m) above sea level. The route led through a high plateau between the eastern and western chains of the Andes, passing sparse vegetation such as cacti and Schinus molle, as well as herds of llamas. The altitude caused agricultural difficulties, since nocturnal cooling often resulted in frozen crops. Before reaching Calpi, they visited Lican, once an important settlement before the Spanish conquest, but now reduced to a small village. Indigenous people believed that wild llamas on Chimborazo descended from domesticated herds scattered after the destruction of Lican. The travelers spent the night in Calpi, which Humboldt measured at 3,452 yards (3,157 m) meters above sea level. On June 23, they began the main phase of their Chimborazo expedition, choosing a south-southeast route favored by their Indigenous guides, though only a few guides had reached the limits of the perpetual snow. Humboldt observed that Chimborazo was surrounded by step-like, grass-covered plateaus, which he compared to former lake beds and similar terrace formations in the Alps. The flora of these grasslands was dominated by grass species common in northern Europe, with few dicotyledonous herbs and limited floral diversity compared to other Andean peaks. Temperatures in the region varied strongly between day and night, and the mean annual temperature at this elevation was approximately nine degrees Celsius.
== Taxonomy == The death cap is named in Latin as such in the correspondence between the English physician Thomas Browne and Christopher Merrett. It was described by French botanist Sébastien Vaillant in 1727, who gave a succinct phrase name "Fungus phalloides, annulatus, sordide virescens, et patulus" (a phallus-shaped, ring-stemmed, dirty green mushroom with a large 'spreading' cap). In 1821, Elias Magnus Fries described it as Agaricus phalloides, but included all white amanitas within its description. Finally, in 1833, Johann Heinrich Friedrich Link settled on the name Amanita phalloides, after Persoon had named it Amanita viridis 30 years earlier. Although Louis Secretan's use of the name A. phalloides predates Link's, it has been rejected for nomenclatural purposes because Secretan's works did not use binomial nomenclature consistently; some taxonomists have, however, disagreed with this opinion. Amanita phalloides is the type species of Amanita section Phalloideae, a group that contains all of the deadly poisonous Amanita species thus far identified. Most notable of these are the species known as destroying angels, including A. virosa, A. bisporigera, A. ocreata, A. verna, and more than a dozen others. The term "destroying angel" has been applied to A. phalloides at times, but "death cap" is by far the most common vernacular name used in English. Other common names also listed include "stinking amanita" and "deadly amanita". A rarely appearing, all-white form was initially described A. phalloides f. alba by Max Britzelmayr, though its status has been unclear.
While these developments took place in the North, liberation movements against British presence in Aden Colony and the Aden Protectorate broke out, resulting to the formation in 1967 of a socialist state, (and hence a Soviet ally) in the Southern Arabian region. It became known as the People's Democratic Republic of Yemen (PDRY) from 1970. The PDRY was involved in the internal disputes of its northern counterpart. It had previously supported the republicans in fighting off Saudi Arabia's influence, but it was the Hamdi regime (1974 to 1977) in the Yemen Arab Republic (North Yemen) that was most notorious for its policies that aimed to reduce Saudi presence in Yemeni politics. Hamdi's rule was, nonetheless, short-lived. A period of political unrest marked by the assassination of former presidents led to Colonel Ali Abdullah Saleh's rise to the presidency of the Yemen Arab Republic. Saleh's rule lasted for 33 years, from 1978 until 2012. The major event that marked his regime was the unification of Yemen in 1990. His attempt was not entirely successful as a civil war broke out in 1994. However, he was able to come out of it victorious. The Republic of Yemen became constitutionally established in 1991. Saleh tried to maintain his position through constitutional amendments, hoping for his son to take over, but strong opposition and protests pressured him out of office by 2012.
The interval between the award and the accomplishment it recognises varies from discipline to discipline. The Literature Prize is typically awarded to recognise a cumulative lifetime body of work rather than a single achievement. The Peace Prize can also be awarded for a lifetime body of work. For example, 2008 laureate Martti Ahtisaari was awarded for his work to resolve international conflicts. However, they can also be awarded for specific recent events. For instance, Kofi Annan was awarded the 2001 Peace Prize just four years after becoming the Secretary-General of the United Nations. Similarly Yasser Arafat, Yitzhak Rabin, and Shimon Peres received the 1994 award, about a year after they successfully concluded the Oslo Accords. A controversy was caused by awarding the 2009 Nobel Peace Prize to Barack Obama during his first year as US president. Awards for physics, chemistry, and medicine are typically awarded once the achievement has been widely accepted. Sometimes, this takes decades – for example, Subrahmanyan Chandrasekhar shared the 1983 Physics Prize for his 1930s work on stellar structure and evolution. Not all scientists live long enough for their work to be recognised. Some discoveries can never be considered for a prize if their impact is realised after the discoverers have died.
== External links == Pale Saints discography at Discogs Pale Saints at IMDb Big Beautiful Bluebottle – Ian Masters's current project. Kuchen – Meriel Barham's current project. Rykarda Parasol – one of Colleen Browne's former bands.
Sources: en.wikipedia.org
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.
No regulatory agency has approved it for routine medical use. It remains an investigational compound studied in controlled trials. Access outside research settings is not established.
Each receptor influences energy balance through different pathways. Combining them is intended to add fat loss from lowered intake and higher expenditure. The optimal balance among the three effects is still under study.
尚未。它仍处于临床研究阶段，任何监管批准都取决于正在进行的试验结果和提交审评。可公开获取的信息以试验注册和会议摘要为主。